Log in to your Inderes Free account to see all free content on this page.
Scandidos
1.77
SEK
+2.31 %
SDOS
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
+2.31%
+7.27%
+17.22%
-2.75%
-12.81%
-7.81%
-44.16%
-50.83%
-87.19%
scandidos.com/investors
Scandidos are active in medical technology. The company provides products and systems for quality assurance of advanced radiation therapy against cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.
Revenue
60.43M
EBIT %
-22.31 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
SDOS
Daily low / high price
1.7 / 1.79
SEK
Market cap
100.91M SEK
Turnover
101.25K SEK
Volume
58K
Latest videos
Financial calendar
Interim report
17.12.2024
Interim report
12.03.2025
Annual report
18.06.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Spore Invest AB | 29.5 % | 29.5 % |
Commerzbank AG, W8IMY - IBA Dosimetry | 10.1 % | 10.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Successful user meeting in Madrid highlights ScandiDos' innovative solutions
ScandiDos receives orders worth €478 000 from China
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio